DRD2 rs18000497 polymorphism is a pharmacogenetic marker in schizophrenia patients on haloperidol Oct. 15, 2021
Knocking down Snai1 rescues right ventricular failure in rats by blockade of EtM transition Oct. 15, 2021
Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases Oct. 14, 2021
Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists Oct. 14, 2021
RSS